Human, Mouse, Cynomolgus Macaque, Dog, Rat, Rabbit
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Light Chains
lambda
Conjugate
Unconjugated
Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 150 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
SDS-PAGE analysis of Avelumab Biosimilar - Anti-PD-L1 Antibody - Low endotoxin, Azide free (A323294) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Avelumab Biosimilar - Anti-PD-L1 Antibody - Low endotoxin, Azide free (A323294) confirms that the purity of this antibody is 98.22%.
Avelumab Biosimilar - Anti-PD-L1 Antibody - Low endotoxin, Azide free (A323294) inhibited the tumor growth of MC38 on hLAG3 mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 32.6% at 1 mpk at D28.
Publishing research using Avelumab Biosimilar - Anti-PD-L1 Antibody - Low endotoxin, Azide free (A323294)? Please let us know so that we can list the citation on this page.
Alternative products to Avelumab Biosimilar - Anti-PD-L1 Antibody - Low endotoxin, Azide free (A323294)